- Home
- LQDA
LQDA
Liquidia Corporation
as 04-18-2025 1:39pm EST
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | MORRISVILLE |
| Market Cap: | N/A | IPO Year: | 2018 |
| Target Price: | $28.33 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.26 - $16.81 | Next Earning Date: | 05-12-2025 |
| Revenue: | $13,996,000 | Revenue Growth: | -19.97% |
| Revenue Growth (this year): | 218.03% | Revenue Growth (next year): | 243.03% |
Stock Insider Trading Activity of Liquidia Corporation (LQDA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Moomaw Scott | LQDA | Chief Commercial Officer | Apr 14 '25 | Sell | $13.57 | 3,406 | $46,219.42 | 214,744 | |
| Kaseta Michael | LQDA | CFO and COO | Apr 14 '25 | Sell | $13.57 | 8,283 | $112,400.31 | 396,315 | |
| Saggar Rajeev | LQDA | Chief Medical Officer | Apr 14 '25 | Sell | $13.57 | 3,714 | $50,398.98 | 265,602 | |
| Schundler Russell | LQDA | General Counsel | Apr 14 '25 | Sell | $13.57 | 5,964 | $80,931.48 | 570,301 | |
| Adair Jason | LQDA | Chief Business Officer | Apr 11 '25 | Sell | $13.57 | 1,856 | $25,185.92 | 184,304 | |
| Moomaw Scott | LQDA | Chief Commercial Officer | Feb 28 '25 | Sell | $15.45 | 592 | $9,146.40 | 214,744 | |
| Kaseta Michael | LQDA | CFO and COO | Feb 28 '25 | Sell | $15.45 | 874 | $13,503.30 | 396,315 | |
| Adair Jason | LQDA | Chief Business Officer | Feb 28 '25 | Sell | $15.45 | 451 | $6,967.95 | 184,304 | |
| Schundler Russell | LQDA | General Counsel | Feb 28 '25 | Sell | $15.45 | 930 | $14,368.50 | 570,301 | |
| Adair Jason | LQDA | Chief Business Officer | Jan 27 '25 | Sell | $14.20 | 445 | $6,319.00 | 184,304 |
Latest Liquidia Corporation News
LQDA Breaking Stock News: Dive into LQDA Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
Great week for Liquidia Corporation (NASDAQ:LQDA) institutional investors after losing 1.5% over the previous year
GlobeNewswire
18 days ago
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
18 days ago
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
MT Newswires
22 days ago
Liquidia Says FDA to Review New Drug Application for Yutrepia
GlobeNewswire
22 days ago
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
GlobeNewswire
23 days ago
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
Simply Wall St.
a month ago
Discover 3 Top Growth Companies With Significant Insider Ownership
GuruFocus.com
a month ago
Earnings To Watch: Liquidia Corp (LQDA) Reports Q4 2024 Result
Compare LQDA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LQDA Liquidia Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.